...Vedat Cilingir; Muhammed Batur Background: This study aimed to investigate whether there are differences in the axonal degeneration rate between patients in the early years of relapsing-remitting multiple sclerosis (RRMS) disease and RRMS patients in their later years. Methods: The early-stage RRMS...

..., Bar-Or A, Panzara M, Sarkar N, Agarwal S, Langer-Gould A, Smith CH, HERMES Trial Group: B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008;358:676–688. 8. Comi G, Pulizzi A, Rovaris M, Abramsky O, Arbizu T, Boiko A, Gold R, Havrdova E, Komoly S, Selmaj K...

... treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon B: implications for clinical trials. Ann Neurol 2002;52:400–406. 11. McDonald I, et al: Recommended diagnostic criteria for MS. Ann Neurol 2001;50:121–127. 12. Rudick RA, Cutter G...

...-remitting multiple sclerosis who were treated with methylprednisolone due to the relapse of the disease. The control groups consisted of 20 patients during the stable stage of relapsing-remitting multiple sclerosis and of 15 patients with noninflammatory diseases of the nervous system. Both chemokines were...

... driving ability, especially in cases with ambiguous neuropsychological results. Relapsing-remitting multiple sclerosis Expanded Disability Status Scale Multiple Sclerosis Functional Composite Driving simulator Patients with multiple sclerosis (MS) show sensomotoric deficits as well...